# Gene Regulation by Thiazolidinediones

> **NCT00567593** · PHASE4 · COMPLETED · sponsor: **James Lewis** · enrollment: 12 (actual)

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Rosiglitazone

## Key facts

- **NCT ID:** NCT00567593
- **Lead sponsor:** James Lewis
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2008-03
- **Final completion:** 2008-03
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2016-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00567593

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00567593, "Gene Regulation by Thiazolidinediones". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00567593. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*